Literature DB >> 30457847

Circulating miRNAs Associated with Arsenic Exposure.

Rowan Beck1,2, Paige Bommarito3, Christelle Douillet4, Matt Kanke5, Luz M Del Razo6, Gonzalo García-Vargas7, Rebecca C Fry3, Praveen Sethupathy5, Miroslav Stýblo4.   

Abstract

Arsenic (As) is a toxic metalloid. Inorganic arsenic (iAs) is a form of As commonly found in drinking water and in some foods. Overwhelming evidence suggests that people chronically exposed to iAs are at risk of developing cancer or cardiovascular, neurological, and metabolic diseases. Although the mechanisms underlying iAs-associated illness remain poorly characterized, a growing body of literature raises the possibility that microRNAs (miRNAs), post-transcriptional gene suppressors, may serve as mediators and/or early indicators of the pathologies associated with iAs exposure. To characterize the circulating miRNA profiles of individuals chronically exposed to iAs, samples of plasma were collected from 109 healthy residents of the city of Zimapán and the Lagunera area in Mexico, the regions with historically high exposures to iAs in drinking water. These plasma samples were analyzed for small RNAs using high-throughput sequencing and for iAs and its methylated metabolites. Associations between plasma levels of arsenic species and miRNAs were evaluated. Six circulating miRNAs (miRs-423-5p, -142-5p -2, -423-5p +1, -320c-1, -320c-2, and -454-5p), two of which have been previously linked to cardiovascular disease and diabetes (miRs-423-5p, -454-5p), were found to be significantly correlated with plasma MAs. No miRNAs were associated with plasma iAs or DMAs after correction for multiple testing. These miRNAs may represent mechanistic links between iAs exposure and disease or serve as markers of disease risks associated with this exposure.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30457847      PMCID: PMC7036137          DOI: 10.1021/acs.est.8b06457

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  76 in total

1.  Exposures to arsenite and methylarsonite produce insulin resistance and impair insulin-dependent glycogen metabolism in hepatocytes.

Authors:  Chongben Zhang; Emily M J Fennel; Christelle Douillet; Miroslav Stýblo
Journal:  Arch Toxicol       Date:  2017-09-26       Impact factor: 5.153

2.  Hypertension and arsenic exposure in Bangladesh.

Authors:  M Rahman; M Tondel; S A Ahmad; I A Chowdhury; M H Faruquee; O Axelson
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

Review 3.  MicroRNAs in hypertension: mechanisms and therapeutic targets.

Authors:  Sándor Bátkai; Thomas Thum
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

Review 4.  Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders.

Authors:  Zhen-Yu Yao; Wen-Bin Chen; Shan-Shan Shao; Shi-Zhan Ma; Chong-Bo Yang; Meng-Zhu Li; Jia-Jun Zhao; Ling Gao
Journal:  J Zhejiang Univ Sci B       Date:  2018 Mar.       Impact factor: 3.066

Review 5.  Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges.

Authors:  V De Guire; R Robitaille; N Tétreault; R Guérin; C Ménard; N Bambace; P Sapieha
Journal:  Clin Biochem       Date:  2013-04-03       Impact factor: 3.281

6.  Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapán and Lagunera regions in Mexico.

Authors:  Luz M Del Razo; Gonzalo G García-Vargas; Olga L Valenzuela; Erika Hernández Castellanos; Luz C Sánchez-Peña; Jenna M Currier; Zuzana Drobná; Dana Loomis; Miroslav Stýblo
Journal:  Environ Health       Date:  2011-08-24       Impact factor: 5.984

Review 7.  Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review.

Authors:  Elizabeth A Maull; Habibul Ahsan; Joshua Edwards; Matthew P Longnecker; Ana Navas-Acien; Jingbo Pi; Ellen K Silbergeld; Miroslav Styblo; Chin-Hsiao Tseng; Kristina A Thayer; Dana Loomis
Journal:  Environ Health Perspect       Date:  2012-08-10       Impact factor: 9.031

8.  A prospective study of arsenic exposure, arsenic methylation capacity, and risk of cardiovascular disease in Bangladesh.

Authors:  Yu Chen; Fen Wu; Mengling Liu; Faruque Parvez; Vesna Slavkovich; Mahbub Eunus; Alauddin Ahmed; Maria Argos; Tariqul Islam; Muhammad Rakibuz-Zaman; Rabiul Hasan; Golam Sarwar; Diane Levy; Joseph Graziano; Habibul Ahsan
Journal:  Environ Health Perspect       Date:  2013-05-10       Impact factor: 9.031

9.  Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients.

Authors:  Cristhianna V A Collares; Adriane F Evangelista; Danilo J Xavier; Diane M Rassi; Thais Arns; Maria C Foss-Freitas; Milton C Foss; Denis Puthier; Elza T Sakamoto-Hojo; Geraldo A Passos; Eduardo A Donadi
Journal:  BMC Res Notes       Date:  2013-11-26

10.  Circulating microRNA signature for the diagnosis of childhood dilated cardiomyopathy.

Authors:  Meng Jiao; Hong-Zhao You; Xin-Ying Yang; Hui Yuan; Yu-Lin Li; Wen-Xian Liu; Mei Jin; Jie Du
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

View more
  8 in total

1.  Health effects of arsenic exposure in Latin America: An overview of the past eight years of research.

Authors:  Khalid M Khan; Rishika Chakraborty; Jochen Bundschuh; Prosun Bhattacharya; Faruque Parvez
Journal:  Sci Total Environ       Date:  2019-12-12       Impact factor: 7.963

Review 2.  Mechanistic understanding of the toxic effects of arsenic and warfare arsenicals on human health and environment.

Authors:  Suhail Muzaffar; Jasim Khan; Ritesh Srivastava; Marina S Gorbatyuk; Mohammad Athar
Journal:  Cell Biol Toxicol       Date:  2022-04-01       Impact factor: 6.691

Review 3.  Origins, fate, and actions of methylated trivalent metabolites of inorganic arsenic: progress and prospects.

Authors:  Miroslav Stýblo; Abhishek Venkatratnam; Rebecca C Fry; David J Thomas
Journal:  Arch Toxicol       Date:  2021-03-26       Impact factor: 5.153

4.  Urinary metals and maternal circulating extracellular vesicle microRNA in the MADRES pregnancy cohort.

Authors:  Caitlin G Howe; Helen B Foley; Shohreh F Farzan; Thomas A Chavez; Mark Johnson; John D Meeker; Theresa M Bastain; Carmen J Marsit; Carrie V Breton
Journal:  Epigenetics       Date:  2021-10-30       Impact factor: 4.861

Review 5.  Toxic-Metal-Induced Alteration in miRNA Expression Profile as a Proposed Mechanism for Disease Development.

Authors:  David R Wallace; Yasmeen M Taalab; Sarah Heinze; Blanka Tariba Lovaković; Alica Pizent; Elisavet Renieri; Aristidis Tsatsakis; Ammad Ahmad Farooqi; Dragana Javorac; Milena Andjelkovic; Zorica Bulat; Biljana Antonijević; Aleksandra Buha Djordjevic
Journal:  Cells       Date:  2020-04-07       Impact factor: 6.600

Review 6.  microRNA exchange via extracellular vesicles in cancer.

Authors:  Luyen Tien Vu; Jinhua Gong; Thach Tuan Pham; Yeokyeong Kim; Minh T N Le
Journal:  Cell Prolif       Date:  2020-10-06       Impact factor: 6.831

Review 7.  Epigenetic Regulation in Exposome-Induced Tumorigenesis: Emerging Roles of ncRNAs.

Authors:  Miguel Ángel Olmedo-Suárez; Ivonne Ramírez-Díaz; Andrea Pérez-González; Alejandro Molina-Herrera; Miguel Ángel Coral-García; Sagrario Lobato; Pouya Sarvari; Guillermo Barreto; Karla Rubio
Journal:  Biomolecules       Date:  2022-03-28

Review 8.  Arsenic-induced changes in miRNA expression in cancer and other diseases.

Authors:  Ana P Ferragut Cardoso; Karen T Udoh; J Christopher States
Journal:  Toxicol Appl Pharmacol       Date:  2020-10-28       Impact factor: 4.219

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.